A Safety Study in Patients With Major Depressive Disorder



Status:Archived
Conditions:Depression, Major Depression Disorder (MDD)
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:October 2010
End Date:August 2012

Use our guide to learn which trials are right for you!

Long-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment


The primary objective of this study is to evaluate the long-term safety and tolerability of
LY2216684 administered once daily (QD) in the adjunctive treatment with a selective
serotonin reuptake inhibitor (SSRI) for up to approximately 1 year in patients with major
depressive disorder (MDD) who are partial responders to their SSRI treatment.



We found this trial at
12
sites
?
mi
from
Santa Fe, NM
Click here to add this to my saved trials
1 South Prospect Street
Burlington, Vermont 05401
802-656-8990
?
mi
from
Burlington, VT
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials
506 6th St
Brooklyn, New York 11215
(718) 780-3000
New York Methodist Hospital A voluntary, acute-care teaching hospital, New York Methodist Hospital's mission is...
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials
?
mi
from
Fayetteville, AR
Click here to add this to my saved trials
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
?
mi
from
Topeka, KS
Click here to add this to my saved trials
Washington D.C., Washington DC 20422
?
mi
from
Washington D.C., DC
Click here to add this to my saved trials